CClinicalTrials.gg
Not yet recruitingNCT06442007Mindset-PKUpdated Dec 10, 2024

Universally Delivered Interventions for Young People

An interventional study of Behavioral Activation - single session intervention (BA-SSI) and 4-session Mindset intervention in Distress, Emotional, sponsored by Pakistan Institute of Living and Learning. Not yet recruiting at 1 site in Pakistan. Open to participants aged 12 Years to 15 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-10.

Sponsored by Pakistan Institute of Living and Learning · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
564
Allocation
Randomized
Ages
12 Years to 15 Years
Sex
All
01

Study summary

Mental health problems are amongst the major contributors to disease burden globally.

According to a recent study, 34% of young people worldwide (aged 10-19) suffer from depression and more than half of this population belongs to Southeast Asia such as Pakistan, India, and China.

Existing evidence shows that the access to mental health services in LMICs is limited and even fewer child psychiatric services are available.

One approach to overcome barriers such as limited availability of trained mental health professionals and risk of stigma may involve the use of simple, brief, scalable interventions based on basic psychological principles rather than treatment of psychopathology.

This study adapts and evaluates two brief interventions called behavioral activation single session intervention (BA-SSI) and 4-session Mindset intervention (MI) for teenage depression and anxiety in Pakistan, where access to mental health care is constrained by societal stigma and a shortage of clinicians.

Read the detailed description

A 3-arm multi-center cluster exploratory Randomized Controlled Trial to determine the feasibility, acceptability and preliminary effectiveness of a universally delivered, culturally adapted, potentially low cost, 4-session Mindset intervention (MI) and behavioral activation single session intervention (BA-SSI) for school going young persons (YP) (12-15 years) in Pakistan.

Proposed study is designed using the updated Medical Research Council (MRC) Framework for the development and evaluation of complex interventions.

Three public schools will be recruited from each of 10 cities across Pakistan: Karachi, Hyderabad, Nawabshah, Thatta, Lahore, Gujrat, Rawalpindi, Multan, Quetta, and Peshawar.

All the participants, regardless of their treatment arm, will be assessed at baseline, 1 month post-baseline and at 3-month.

02

Conditions studied

  • Distress, Emotional

Keywords

  • adolescents
  • anxiety
  • depression
  • single session interventions
  • growth mindset
  • Pakistan
03

Who can participate

Ages eligible
12 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Young persons (YP)

Inclusion criteria

Inclusion Criteria:

  • Youth is between the age 12-15 years (inclusive) at the time of study enrollment.
  • Youth has one parent or legal guardian to give consent.
  • Youth speaks Urdu well enough to complete the paper based intervention.

Exclusion criteria

Exclusion Criteria:

  • Intellectual disability, as this may undermine comprehension of intervention material.
  • Adolescent with history of hospitalization or those who received inpatient treatment for a mental health problem within the past two months as the intervention being tested and this study is not designed for adolescent with acute medical and/or psychiatric treatment needs (if identified with any acute medical and/or psychiatric problem, they would be referred to appropriate health services through parents).

Schools Inclusion Criteria

Schools in the study areas are eligible to participate if they meet all the following criteria:

  1. the school authority agrees to participate;
  2. the schools shall be non-specialist public schools;
  3. school contains at least 80 students; Exclusion criteria

If the school meet the following exclusion criteria, they are ineligible to participate:

  1. the school authority refuses to participate;
  2. a specialist and/or independent or private school;
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
564 participants (estimated)

Study arms

  • Experimental
    Behavioral Activation - single session intervention (BA-SSI)

    This is comprised of 5 five components: 1. Discussion on the rationale of the behavioral activation 2. Awareness raising about distress, including how behavior shapes feelings and thoughts; 3. a life values assessment 4. the creation of an activity action plan 5. an exercise in which youths write about benefits that might result from engaging in each activity, an obstacle that might keep them from doing the activities and a strategy for overcoming the identified obstacles.

    Behavioral: Behavioral Activation - single session intervention (BA-SSI)

  • Active comparator
    4-session Mindset intervention

    This is comprised of a growth mindset module (2 sessions), a gratitude module (1 session) and a value affirmations module (1 session). Sessions are delivered weekly (over 4 weeks) and each session lasts for an hour. Reading and writing activities and group discussions are included in each session. Participants are supposed to complete homework exercises are assigned between sessions.

    Behavioral: 4-session Mindset intervention

  • No intervention
    Waiting list control group

    At end of the study, this group will be offered to choose one intervention from two active interventions mentioned above.

Interventions

  • BehavioralBehavioral Activation - single session intervention (BA-SSI)

    Single session intervention

  • Behavioral4-session Mindset intervention

    This is comprised of 4 sessions.

05

What researchers measure

Primary outcomes

  1. Feasibility of recruitment

    This will be monitored through a research trial log. This log will include information about number of schools approached, number of schools eligible to participate, number of schools consented to participate, number of YP approached, number of eligible YP and number of those who consented to participate

    Time frame: Total recruitment period is 3 months. Change in numbers will be recorded from first month of recruitment to 3rd month of recruitment

  2. Feasibility of intervention

    Session attendance for each participant in active study arms for each session will be recorded and maintained in participant intervention log.

    Time frame: Retention of participants in the Intervention at the completion of one month intervention period.

  3. Depression

    The Patient Health Questionnaire -8 will be used to assess the symptoms of depression. PHQ-8 scores are highly correlated with PHQ-9 scores, and the same cutoffs can be used to assess depression severity

    Time frame: Change in scores from baseline to 3-month follow up.

Secondary outcomes

  1. The Revised Child Anxiety and Depression Scale

    It is a 47-item, youth self-report questionnaire with subscales including: separation anxiety disorder (SAD), social phobia (SP), generalized anxiety disorder (GAD), panic disorder (PD), obsessive compulsive disorder (OCD), and major depressive disorder (MDD). It also yields a Total Anxiety Scale (sum of the 5 anxiety subscales) and a Total Internalizing Scale (sum of all 6 subscales). Items are rated on a 4-point Likert-scale from 0 ("never") to 3 ("always").

    Time frame: Change in scores from baseline to 3-month follow up

  2. Growth Mindset scale

    The mindset scale is comprised of 3 items regarding participants' views about the mindset such as intelligence, personality etc. There is not cutoff score. Higher total summed scores indicate stronger fixed mindsets, and lower scores, stronger growth mindsets.

    Time frame: Change in scores from baseline to 3-month follow up

  3. Beck's hopelessness Scale short version

    A 4-item short version of the Hopelessness Scale includes all the affective, cognitive and motivational components of hopelessness.

    Time frame: Change in scores from baseline to 3-month follow up

  4. EuroQol Quality of Life scale

    This scale provides a simple descriptive profile and a single index value for health status that can be used in the clinical and economic evaluation of health care as well as in population health surveys. higher score indicare greater disability. there is no cutoff score.

    Time frame: Change in scores from baseline to 3-month follow up

  5. Program Feedback Scale

    youths will be asked to complete a series of questions regarding their experience with the intervention to which they were assigned. highre score will indicate greater level of acceptability. there is no cut off score.

    Time frame: Total acceptability score at completion of one month intervention period.

06

Study locations

1 site
  • Public school for boys 1
    Rawalpindi, Punjab, Pakistan
07

References and documents

Individual participant data

Plan to share: No — This is the feasibility study and interventions will continue to refine and adapt. The IP is owned by the Pakistan Institute of Living and Learning

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT06442007
Lead sponsor
Pakistan Institute of Living and Learning
Collaborators
Fatima Jinnah Women University
Responsible party
Sponsor
First posted
Jun 4, 2024
Start date
May 1, 2025 (estimated)
Primary completion
Oct 30, 2025 (estimated)
Completion
Dec 30, 2025 (estimated)
Last update
Dec 10, 2024

Study contacts

Tayyeba Kiran, PhD
Contact
tayyebakiran@gmail.com
0923328262142

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion